Nov 09, 2018 - Celldex (CLDX) reports narrower-than-expected loss in Q3. Revenues fall on reduced contract revenues and also miss estimates.
Nov 09, 2018 - Spectrum (SPPI) reports narrower-than-expected loss in the third quarter and also beats on revenues. The company is on track to file a BLA for Rolontis by year end.
Nov 08, 2018 - Jazz Pharmaceuticals (JAZZ) lowers sales guidance for 2018. Stock declines 14% following the release of third-quarter earnings.
Oct 31, 2018 - Impressive third-quarter results by most biotech bigwigs were the key highlights of the week. Most companies upped their guidance.
Oct 30, 2018 - We expect CRISPR (CRSP) to provide updates on its pipeline candidates in the third quarter of 2018.
Oct 29, 2018 - Vertex is a $42 bn market cap biotech company that showed unprecedented success over the last several years in the treatment of cystic fibrosis.We believe that Vertex will eventually be able to treat
Oct 26, 2018 - H.C. Wainwright issues rating change for VRTX
Oct 24, 2018 - Vertex Pharmaceuticals, Inc. (NASDAQ:VRTX)Q3 2018 Earnings CallOctober 24, 2018 4:30 pm ETExecutivesMichael Partridge - Vertex Pharmaceuticals, Inc.Jeffrey M. Leiden - Vertex Pharmaceuticals, Inc.Ian
Oct 24, 2018 - The following slide deck was published by Vertex Pharmaceuticals Incorporated in conjunction with their 2018 Q3 earnings call.
Oct 23, 2018 - Three biotech stocks are scheduled to release their third-quarter results on Oct 24. Let's take a look at how these companies are poised ahead of their earnings release.